Icotinib
CAS: 610798-31-7
Ref. TM-T6153
| 1mg | 48.00 € | ||
| 2mg | 63.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 152.00 € | ||
| 25mg | 276.00 € | ||
| 50mg | 518.00 € | ||
| 100mg | 700.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
Product Information
Name:
Icotinib
Synonyms:
- Conmana
- BPI-2009H
- BPI-2009
- Bpi 2009H
- Icotinib int. N-1
- N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine
- [1,4,7,10]Tetraoxacyclododecino[2,3-g]quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-
Description:
Icotinib (Conmana) is an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
391.42
Formula:
C22H21N3O4
Purity:
100%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T6153 Icotinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
